These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27645169)

  • 1. Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer's disease.
    Wang YY; Zheng W; Ng CH; Ungvari GS; Wei W; Xiang YT
    Int J Geriatr Psychiatry; 2017 Jan; 32(1):50-57. PubMed ID: 27645169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chinese Medicine for Alzheimer's Disease: A Meta-Analysis of Randomized Controlled Trials.
    Ma HK; Liu Y; Li B; Zhang Y; Sun LJ; Xu FQ
    Chin J Integr Med; 2018 Dec; 24(12):938-943. PubMed ID: 30242591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinesterase inhibitor discontinuation in patients with Alzheimer's disease: a meta-analysis of randomized controlled trials.
    O'Regan J; Lanctôt KL; Mazereeuw G; Herrmann N
    J Clin Psychiatry; 2015 Nov; 76(11):e1424-31. PubMed ID: 26646039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia.
    Asayama K; Yamadera H; Ito T; Suzuki H; Kudo Y; Endo S
    J Nippon Med Sch; 2003 Aug; 70(4):334-41. PubMed ID: 12928714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dose and Duration-dependent Association between Melatonin Treatment and Overall Cognition in Alzheimer's Dementia: A Network Meta- Analysis of Randomized Placebo-Controlled Trials.
    Tseng PT; Zeng BY; Chen YW; Yang CP; Su KP; Chen TY; Wu YC; Tu YK; Lin PY; Carvalho AF; Stubbs B; Matsuoka YJ; Li DJ; Liang CS; Hsu CW; Sun CK; Cheng YS; Yeh PY; Shiue YL
    Curr Neuropharmacol; 2022; 20(10):1816-1833. PubMed ID: 35450525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials.
    Zhang W; Chen XY; Su SW; Jia QZ; Ding T; Zhu ZN; Zhang T
    Neurol Sci; 2016 Jan; 37(1):57-65. PubMed ID: 26255301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials.
    Bedward A; Kaur J; Seedat S; Donohue H; Kow CS; Rasheed MK; Javed A; Hasan SS
    Expert Rev Neurother; 2024 May; 24(5):527-539. PubMed ID: 38597219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin in autism spectrum disorders: a systematic review and meta-analysis.
    Rossignol DA; Frye RE
    Dev Med Child Neurol; 2011 Sep; 53(9):783-792. PubMed ID: 21518346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Melatonin on Benzodiazepine Discontinuation and Sleep Quality in Adults Attempting to Discontinue Benzodiazepines: A Systematic Review and Meta-Analysis.
    Wright A; Diebold J; Otal J; Stoneman C; Wong J; Wallace C; Duffett M
    Drugs Aging; 2015 Dec; 32(12):1009-18. PubMed ID: 26547856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Influence of Melatonin on Sleep Quality After Laparoscopic Cholecystectomy: A Meta-Analysis of Randomized Controlled Trials.
    Zhang J; Wang Y; Xu H; Yang J
    Surg Laparosc Endosc Percutan Tech; 2019 Feb; 29(1):1-6. PubMed ID: 30531447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease.
    Liao Z; Cheng L; Li X; Zhang M; Wang S; Huo R
    Clin Neuropharmacol; 2020; 43(4):93-99. PubMed ID: 32658034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    Kubo M; Kishi T; Matsunaga S; Iwata N
    J Alzheimers Dis; 2015; 48(3):667-71. PubMed ID: 26402104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
    Zheng W; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Sun F; D'Arcy C; Meng X; Xiang YT
    Hum Psychopharmacol; 2016 Jul; 31(4):286-95. PubMed ID: 27302211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine Augmentation With Antiepileptic Drugs for Treatment-Resistant Schizophrenia: A Meta-Analysis of Randomized Controlled Trials.
    Zheng W; Xiang YT; Yang XH; Xiang YQ; de Leon J
    J Clin Psychiatry; 2017 May; 78(5):e498-e505. PubMed ID: 28355041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic Efficacy of Melatonin: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials.
    Oh SN; Myung SK; Jho HJ
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32455582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mindfulness-Based Interventions for Insomnia: A Meta-Analysis of Randomized Controlled Trials.
    Wang YY; Wang F; Zheng W; Zhang L; Ng CH; Ungvari GS; Xiang YT
    Behav Sleep Med; 2020; 18(1):1-9. PubMed ID: 30380915
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials.
    Gauthier S; Proaño JV; Jia J; Froelich L; Vester JC; Doppler E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):332-47. PubMed ID: 25832905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease: A Systematic Review and Network Meta-Analysis.
    Terao I; Kodama W
    J Alzheimers Dis; 2024; 98(3):825-835. PubMed ID: 38461503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials.
    Sumsuzzman DM; Choi J; Jin Y; Hong Y
    Neurosci Biobehav Rev; 2021 Aug; 127():459-473. PubMed ID: 33957167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.
    Liu J; Wang LN; Jia JP
    Drugs Aging; 2015 Jan; 32(1):57-65. PubMed ID: 25504005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.